Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lowered by equities researchers at Bernstein Bank from $1,070.00 to $1,000.00 in a research note issued to investors on ...

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

This was the stock's second consecutive day of gains.

The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...

Today, W. Capra announced that the recently acquired Impact 21 business will be operating fully as W. Capra and unveiled a new company brand to reflect the change.

OpenAI has rebranded its look with tweaks to its signature blossom logo and a new typeface called OpenAI Sans, hoping to have a more approachable and human image.

MicroStrategy, the business intelligence firm and Bitcoin treasury company co-founded by Michael Saylor has rebranded to ...